[Current antimicrobial agent series III: Norfloxacin].
D000818:Animals; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D006801:Humans; D051379:Mice; D009643:Norfloxacin / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use
D009643:Norfloxacin